Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma

Diagnostic Pathology

Volumn 9, Issue 1, 2014, Pages

  Cai, Lizhi ^a   Cai, Xi ^a  

^a YANGTZE UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN92 MICRORNA, HUMAN; TUMOR MARKER;

BIOPSY; CANCER STAGING; CHI SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TIME FACTOR; TUMOR INVASION; UPREGULATION;

BIOMARKERS, TUMOR; BIOPSY; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TIME FACTORS; UP-REGULATION;

EID: 84924262907     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/s13000-014-0228-2     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E: Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004, 127:S17-S26.
3. Nguyen VT, Law MG, Dore GJ: Hepatitis b-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat 2009, 16:453-463.
4. Bartel DP: Micrornas: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Pillai RS: Microrna function: multiple mechanisms for a tiny RNA? RNA 2005, 11:1753-1761.
6. Zamore PD, Haley B: Ribo-gnome: the big world of small RNAs. Science 2005, 309:1519-1524.
7. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z: Identification of hundreds of conserved and nonconserved human micrornas. Nat Genet 2005, 37:766-770.
8. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E: Phylogenetic shadowing and computational identification of human microrna genes. Cell 2005, 120:21-24.
9. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 2005, 120:15-20.
10. Hwang HW, Mendell JT: Micrornas in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006, 94:776-780.
11. Wienholds E, Plasterk RH: Microrna function in animal development. FEBS Lett 2005, 579:5911-5922.
12. Jovanovic M, Hengartner MO: Mirnas and apoptosis: RNAs to die for. Oncogene 2006, 25:6176-6187.
13. Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, de Bruijn E, Horvitz HR, Kauppinen S, Plasterk RH: Microrna expression in zebrafish embryonic development. Science 2005, 309:310-311.
14. Shibata M, Nakao H, Kiyonari H, Abe T, Aizawa S: Microrna-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J Neurosci 2011, 31:3407-3422.
15. Delaloy C, Liu L, Lee JA, Su H, Shen F, Yang GY, Young WL, Ivey KN, Gao FB: Microrna-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell 2010, 6:323-335.
16. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, OL J: Potential role of mir-9 and mir-223 in recurrent ovarian cancer. Mol Cancer 2008, 7:35.
17. Khew-Goodall Y, Goodall GJ: Myc-modulated mir-9 makes more metastases. Nat Cell Biol 2010, 12:209-211.
18. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F, Kreipe H: Epigenetic inactivation of microrna gene hsa-mir-9-1 in human breast cancer. J Pathol 2008, 214:17-24.
19. Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P, Wood CG, Wu X: Hsa-mir-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 2010, 29:5724-5728.
20. Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, Ho MR, Lai CH, Kao HW, Fang WL, Huang KH, Lin WC: Aberrant hypermethylation of mir-9 genes in gastric cancer. Epigenetics 2011, 6:1189-1197.
21. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, Meyer HE, Reifenberger G: Identification and functional characterization of micrornas involved in the malignant progression of gliomas. Brain Pathol 2010, 20:539-550.
22. Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W: Microrna-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol 2012, 29:1037-1043.
23. Bonev B, Pisco A, Papalopulu N: Microrna-9 reveals regional diversity of neural progenitors along the anterior-posterior axis. Dev Cell 2011, 20:19-32.
24. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA: Mir-9, a myc/mycn-activated microrna, regulates e-cadherin and cancer metastasis. Nat Cell Biol 2010, 12:247-256.
25. Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X: A microrna expression signature for cervical cancer prognosis. Cancer Res 2010, 70:1441-1448.
26. Tan HX, Wang Q, Chen LZ, Huang XH, Chen JS, Fu XH, Cao LQ, Chen XL, Li W, Zhang LJ: Microrna-9 reduces cell invasion and e-cadherin secretion in sk-hep-1 cell. Med Oncol 2010, 27:654-660.
27. Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M, Li X, Tang H: Microrna-9 inhibits ovarian cancer cell growth through regulation of nf-kappab1. FEBS J 2009, 276:5537-5546.
28. Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H: Regulation of the transcription factor nf-kappab1 by microrna-9 in human gastric adenocarcinoma. Mol Cancer 2010, 9:16.
29. Chen TH, Chang SW, Huang CC, Wang KL, Yeh KT, Liu CN, Lee H, Lin CC, Cheng YW: The prognostic significance of apc gene mutation and mir-21 expression in advanced stage colorectal cancer. Colorectal Dis 2013
30. Agirre X, Vilas-Zornoza A, Jimenez-Velasco A, Martin-Subero JI, Cordeu L, Garate L, San Jose-Eneriz E, Abizanda G, Rodriguez-Otero P, Fortes P, Rifon J, Bandres E, Calasanz MJ, Martin V, Heiniger A, Torres A, Siebert R, Roman-Gomez J, Prosper F: Epigenetic silencing of the tumor suppressor microrna hsa-mir-124a regulates cdk6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res 2009, 69:4443-4453.
31. Marcucci G, Radmacher MD, Maharry K, Mrozek K, Ruppert AS, Paschka P, Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL, Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD: Microrna expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008, 358:1919-1928.
32. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC: Microrna expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425-436.
33. Fiaschetti G, Abela L, Nonoguchi N, Dubuc AM, Remke M, Boro A, Grunder E, Siler U, Ohgaki H, Taylor MD, Baumgartner M, Shalaby T, Grotzer MA: Epigenetic silencing of mirna-9 is associated with hes1 oncogenic activity and poor prognosis of medulloblastoma. Br J Cancer 2014, 110:636-647.
34. Yoon C, Kim D, Kim S, Park GB, Hur DY, Yang JW, Park SG, Kim YS: Mir-9 regulates the post-transcriptional level of vegf165a by targeting srpk-1 in arpe-19 cells. Graefes Arch Clin Exp Ophthalmol 2014, 252:1369-1376.
35. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW: Identification of metastasis-related micrornas in hepatocellular carcinoma. Hepatology 2008, 47:897-907.
36. Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, Gupta S, Liang H, Lin HK, Hung MC, Ma L: Lifr is a breast cancer metastasis suppressor upstream of the hippo-yap pathway and a prognostic marker. Nat Med 2012, 18:1511-1517.